Potentiation of N-methyl-d-aspartate receptor-mediated neuronal injury during methamphetamine withdrawal in vitro requires co-activation of IP3 receptors

Brain Research

Volumn 1187, Issue 1, 2008, Pages 67-73

  Smith, Katherine J ^a   Butler, Tracy R ^a   Self, Rachel L ^a   Braden, Brittany B ^a   Prendergast, Mark A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Amphetamine; Brain injury; Drug abuse; Glutamate; Stimulant

Indexed keywords

5 2 AMINO 5 PHOSPHONOVALERIC ACID; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROPIDIUM IODIDE; UNCLASSIFIED DRUG; XESTOSPONGIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DRUG INHIBITION; DRUG MECHANISM; FEMALE; GRANULE CELL; HIPPOCAMPUS; IN VITRO STUDY; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL;

ANIMALS; ANIMALS, NEWBORN; CELL DEATH; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG INTERACTIONS; DRUG SYNERGISM; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HIPPOCAMPUS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MACROCYCLIC COMPOUNDS; MALE; METHAMPHETAMINE; NERVE DEGENERATION; ORGAN CULTURE TECHNIQUES; OXAZOLES; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANCE WITHDRAWAL SYNDROME;

RATTUS;

EID: 36649000262     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.10.019     Document Type: Article

References (49)

1. Alele D.E., and Devaud L.L. Differential adaptations in GABAergic and glutamatergic systems during ethanol withdrawal in male and female rats. Alcohol. Clin. Exp. Res. 29 6 (2005) 1027-1034
2. Avignone E., Frenguelli B.G., and Irving A.J. Differential responses to NMDA receptor activation in rat hippocampal interneurons and pyramidal cells may underlie enhanced pyramidal cell vulnerability. Eur. J. Neurosci. 22 12 (2005) 3077-3090
3. Bartels C., Kunert H.J., Stawicki S., Kroner-Herwig B., Ehrenreich H., and Krampe H. Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence. Alcohol 42 2 (2007) 92-102
4. Cadet J.L., Krasnova I.N., Jayanthi S., and Lyles J. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox. Res. 11 3-4 (2007) 183-202
5. Chang L., and Haning W. Insights from recent positron emission tomographic studies of drug abuse and dependence. Curr. Opin. Psychiatry 19 3 (2006) 246-252
6. Chung H., Park M., Hahn E., Choi H., Choi H., and Lim M. Recent trends of drug abuse and drug-associated deaths in Korea. Ann. N.Y. Acad. Sci. 1025 (2004) 458-464
7. Davidson M., Shanley B., and Wilce P. Increased NMDA-induced excitability during ethanol withdrawal: a behavioural and histological study. Brain Res. 674 1 (1995) 91-96
8. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Rev. 36 (2001) 1-22
9. 1H MRS Study. Neurology 54 (2000) 1344-1349
10. Gee C.E., Benquet P., Raineteau O., Rietschin L., Kirbach S.W., and Gerber U. NMDA receptors and the differential ischemic vulnerability of hippocampal neurons. Eur. J. Neurosci. 23 10 (2006) 2595-2603
11. Grubbs F. Procedures for detecting outlying observations in samples. Technometrics 11 1 (1969) 1-21
12. Hayashi T., and Su T.P. The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: Implication for drug abuse. Life Sci. 77 (2005) 1612-1624
13. Hayter A.J. The maximum familywise error rate of Fisher's least significant difference test. J. Am. Stat. Assoc. 81 (1986) 1000-1004
14. Jayanthi S., Deng X., Noailles P.-I.H., Ladenheim B., and Cadet J.L. Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB J. 18 (2004) 238-251
15. Kaiya H., Takeuchi K., Yoshida H., Kondo T., Sanpei F., Okada Y., and Namba M. Effects of subchronic treatment of methamphetamine haloperidol on the rat brain levels of GABA, glutamate and aspartate. Folia Psychiatr. Neurol. Jpn. 37 1 (1983) 107-113
16. Kalechstein A.D., Newton T.F., and Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J. Neuropsychiatry Clin. Neurosci. 15 (2003) 215-220
17. Kilts C.D., Schweitzer J.B., Quinn C.K., Gross R.E., Gaber T.L., Muhammad F., Ely T.D., Hoffman J.M., and Drexler K.P. Neural activity related to drug craving in cocaine addiction. Arch. Gen. Psychiatry 58 4 (2001) 334-341
18. Krupp J.J., Vissel B., Heinemann S.F., and Westbrook G.L. Calcium-dependent inactivation of recombinant N-methyl-d-aspartate receptors is NR2 subunit specific. Mol. Pharmacol. 50 6 (1996) 1680-1688
19. Maler J.M., Esselmann H., Wiltfang J., Kunz N., Lewczuk P., Reulbach U., Bleich S., Rǘther E., and Kornhuber J. Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons. Brain Res. 1052 2 (2005) 156-162
20. Mark K.A., Quinton M.S., Russek S.J., and Yamamoto B.K. Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release. J. Neurosci. 27 25 (2007) 6823-6831
21. 3H]kainate binding sites in the rat hippocampus. Anat. Embryol. 198 (1998) 195-204
22. McGregor C., Srisurapanont M., Jittiwutikarn J., Laobhripatr S., Wongtan T., and White J.M. The nature, time course, and severity of methamphetamine withdrawal. Addiction 100 (2005) 1320-1329
23. Melega W.P., Williams A.E., Schmitz D.A., DiStefano E.W., and Cho A.K. Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal. J. Pharmacol. Exp. Ther. 274 1 (1995) 90-96
24. Moriguchi S., Watanabe S., Kita H., and Nakanishi H. Enhancement of N-methyl-d-aspartate receptor-mediated excitatory postsynaptic potentials in the neostriatum after methamphetamine sensitization. Exp. Brain Res. 144 (2002) 238-246
25. Mulholland P.J., and Prendergast M.A. Transection of intrinsic polysynaptic pathways reduces N-methyl-d-aspartate neurotoxicity in hippocampal slice cultures. Neurosci. Res. 46 (2003) 369-376
26. Nakashima K., Kaddoumi A., Ishida Y., Itoh T., and Taki K. Determination of methamphetamine and amphetamine in abusers' plasma and hair samples with HPLC-FL. Biomed. Chromatogr. 17 7 (2003) 471-476
27. Newton T.F., Roache J.D., De La Garza R., Fong T., Wallace C.L., Li S.H., Elkashef A., Chiang N., and Kahn R. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology 31 7 (2006) 1537-1544
28. Prendergast M.A., Harris B.R., Blanchard J.A., Mayer S., Gibson D.A., and Littleton J.M. In vitro effects of ethanol withdrawal and spermidine on viability of hippocampus from male and female rat. Alcohol Clin. Exp. Res. 24 12 (2000) 1855-1861
29. Prendergast M.A., Harris B.R., Mulholland P.J., Blanchard II J.A., Gibson D.A., Holley R.C., and Littleton J.M. Hippocampal CA1 region neurodegeneration produced by ethanol withdrawal requires activation of intrinsic polysynaptic hippocampal pathways and function of N-methyl-d-aspartate receptors. Neuroscience 124 (2004) 869-877
30. Ricaurte G.A., Guillery R.W., Seiden L.S., Schuster C.R., and Moore R.Y. Dopamine nerve terminal degeneration produced by high doses of methamphetamine in the rat brain. Brain Res. 235 (1982) 93-103
31. Rocher C., and Gardier A.M. Effects of repeated systemic administration of d-fenfluramine on serotonin and glutamate release in rat ventral hippocampus: comparison with methamphetamine using in vivo microdialysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 363 4 (2001) 422-428
32. Schneider F., Habel U., Wagner M., Franke P., Salloum J.B., Shah N.J., Toni I., Sulzbach C., Honig K., Maier W., Gaebel W., and Zilles K. Subcortical correlates of craving in recently abstinent alcoholic patients. Am. J. Psychiatry 158 7 (2001) 1075-1083
33. Self R.L., Smith K.J., Mulholland P.J., and Prendergast M.A. Ethanol exposure and withdrawal sensitizes the rat hippocampal CA1 pyramidal cell region to beta-amyloid (25-35)-induced cytotoxicity: NMDA receptor involvement. Alcohol. Clin. Exp. Res. 29 11 (2005) 2063-2069
34. Shin C., and Lee K.H. Epilepsy and cell death. In: Koliatsos V.E., and Ratan R.R. (Eds). Cell Death and Diseases of the Nervous System (1999), Humana Press Inc., Totowa, N. 361-377
35. Simon S.L., Domier C., Carnell J., Brethen P., Rawson R., and Ling W. Cognitive impairment in individuals currently using methamphetamine. J. Addict. Dis. 9 3 (2000) 222-231
36. Smith K.J., Self R.L., Butler T.R., Mullins M.M., Ghayoumi L., Holley R.C., Littleton J.M., and Prendergast M.A. Methamphetamine exposure antagonized N-methyl-d-aspartate receptor-mediated neurotoxicity in organotypic hippocampal slice cultures. Brain Res. 1157 (2007) 74-80
37. Spina M.B., and Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 86 4 (1989) 1398-1400
38. Stefanski R., Justinova Z., Hayashi T., Takebayashi M., Goldberg S.R., and Su T.P. Sigma(1) receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls. Psychopharmacology 75 1 (2004) 68-75
39. Su T.P., and Hayashi T. Cocaine affects the dynamics of cytoskeletal proteins via sigma(1) receptors. Trends Pharmacol. Sci. 22 9 (2001) 456-458
40. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. The NSDUH report. Drug Abuse Warning Network (2007) 1-3. http://oas.samhsa.gov/2k7/meth/meth.htm http://oas.samhsa.gov/2k7/meth/meth.htm.
41. Takahashi S., Miwa T., and Horikomi K. Involvement of sigma 1 receptors in methamphetamine-induced behavioral sensitization in rats. Neurosci. Lett. 289 1 (2000) 21-24
42. Tata D.A., and Yamamoto B.K. Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate, and mitochondrial dysfunction. Addiction 1 (2007) 49-60
43. Thompson P.M., Hayashi K.M., Simon S.L., Geaga J.A., Hong M.S., Sui Y., Lee J.Y., Toga A.W., Ling W., and London E.D. Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci. 24 26 (2004) 6028-6036
44. Ujike H., Kuroda S., and Otsuki S. Sigma receptor antagonists block the development of sensitization to cocaine. Eur. J. Neurosci. 296 2 (1996) 123-128
45. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Franceschi D., Sedler M., Gatley S.J., Miller E., Hitzemann R., Ding Y.S., and Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 21 23 (2001) 9414-9418
46. Yamamoto B.K., and Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J. Pharmacol. Exp. Ther. 287 (1998) 107-114
47. Yeh G.C., Chen J.C., Tsai H.C., Wu H.H., Lin C.Y., Hsu P.C., and Peng Y.C. Amphetamine inhibits the N-methyl-d-aspartate receptor-mediated responses by directly interacting the receptor/channel complex. J. Pharmacol. Exp. Ther. 300 3 (2002) 1008-1016
48. A receptor α2 subunit and GAD67 expression. Biochem. Biophys. Res. Commun. 351 (2006) 300-305
49. Zimmer J., Kristensen B.W., Jakobsen B., and Noraberg J. Excitatory amino acid neurotoxicity and modulation of glutamate receptor expression in organotypic brain slice cultures. Amino Acids 19 (2000) 7-21